Exelixis (EXEL) Income towards Parent Company (2010 - 2026)

Exelixis (EXEL) recorded quarterly Income towards Parent Company of $210.5 million in Q2 2026, down 13.93% quarter-over-quarter from $244.5 million in Q1 2026, and up 31.86% on a YoY basis from $159.6 million in Q2 2025.

Exelixis (EXEL) Income towards Parent Company (2010 - 2026) Analysis & Trends

Exelixis' Income towards Parent Company history runs 17 years deep, the most recent figure standing at $210.5 million for Q2 2026.

  • In Q2 2026, Income towards Parent Company rose 31.86% year-over-year to $210.5 million; the TTM figure through Apr 2026 stood at $833.4 million (up 29.5% YoY), while the FY2026 annual figure was $782.6 million, up 50.13% from the prior year.
  • Income towards Parent Company was $210.5 million for Q2 2026 at Exelixis, down from $244.5 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $244.5 million in Q1 2026 to a low of -$30.2 million in Q4 2022.
  • Historically, Income towards Parent Company has averaged $112.0 million across 5 years, with a median of $85.5 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Income towards Parent Company plunged 131.71% in 2022, then jumped 11232.66% in 2024.
  • A 5-year view of Income towards Parent Company shows it stood at -$30.2 million in 2022, then surged by 383.43% to $85.5 million in 2023, then jumped by 37.95% to $118.0 million in 2024, then jumped by 64.09% to $193.6 million in 2025, then increased by 8.72% to $210.5 million in 2026.
  • The last three Income towards Parent Company figures came in at $210.5 million (Q2 2026), $244.5 million (Q1 2026), and $193.6 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Exelixis 13.61 Bn 12.83 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 210.47 Mn
Jan 2, 2026 244.53 Mn
Oct 3, 2025 193.58 Mn
Jul 4, 2025 184.85 Mn
Apr 4, 2025 159.62 Mn
Jan 3, 2025 139.86 Mn
Sep 27, 2024 117.97 Mn
Jun 28, 2024 226.12 Mn
Mar 29, 2024 37.32 Mn
Dec 29, 2023 85.52 Mn
Sep 29, 2023 1.04 Mn
Jun 30, 2023 81.18 Mn
Mar 31, 2023 40.03 Mn
Dec 30, 2022 -30.17 Mn
Sep 30, 2022 73.21 Mn
Jul 1, 2022 70.67 Mn
Apr 1, 2022 68.57 Mn
Dec 31, 2021 95.17 Mn
Oct 1, 2021 38.20 Mn
Jul 2, 2021 96.09 Mn